4519.T
Price:
$7189
Market Cap:
$11.83T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutic...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2000-01-04
Stock Exchange
JPX
Ticker
4519.T
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 28.86. This represents a change of 7.86% compared to the average of 26.76 of the last 4 quarters.
The mean historical PE Ratio of Chugai Pharmaceutical Co., Ltd. over the last ten years is 32.21. The current 28.86 PE Ratio has changed 8.86% with respect to the historical average. Over the past ten years (40 quarters), 4519.T's PE Ratio was at its highest in in the December 2017 quarter at 50.82. The PE Ratio was at its lowest in in the March 2022 quarter at 12.78.
Average
32.21
Median
34.61
Minimum
14.80
Maximum
43.37
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.51%
Maximum Annual PE Ratio = 43.37
Minimum Annual Increase = -51.88%
Minimum Annual PE Ratio = 14.80
Year | PE Ratio | Change |
---|---|---|
2024 | 29.74 | 10.13% |
2023 | 27.00 | 82.51% |
2022 | 14.80 | -27.00% |
2021 | 20.27 | -51.88% |
2020 | 42.12 | 20.27% |
2019 | 35.02 | -7.26% |
2018 | 37.76 | -12.94% |
2017 | 43.37 | 26.84% |
2016 | 34.19 | -9.68% |
2015 | 37.86 | 19.46% |
The current PE Ratio of Chugai Pharmaceutical Co., Ltd. (4519.T) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
23.85
5-year avg
26.78
10-year avg
32.21
Chugai Pharmaceutical Co., Ltd.’s PE Ratio is greater than Daiichi Sankyo Company, Limited (21.05), less than Astellas Pharma Inc. (47.68), less than Takeda Pharmaceutical Company Limited (62.84), greater than Eisai Co., Ltd. (23.96), greater than Shionogi & Co., Ltd. (12.49),
Company | PE Ratio | Market cap |
---|---|---|
21.05 | $6.13T | |
47.68 | $2.42T | |
62.84 | $6.75T | |
23.96 | $1.11T | |
12.49 | $2.13T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Chugai Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Chugai Pharmaceutical Co., Ltd. (4519.T)?
What is the highest PE Ratio for Chugai Pharmaceutical Co., Ltd. (4519.T)?
What is the 3-year average PE Ratio for Chugai Pharmaceutical Co., Ltd. (4519.T)?
What is the 5-year average PE Ratio for Chugai Pharmaceutical Co., Ltd. (4519.T)?
How does the current PE Ratio for Chugai Pharmaceutical Co., Ltd. (4519.T) compare to its historical average?